Coreline Soft announced on the 13th that it has simultaneously introduced its AI-based lung cancer screening (LCS) and coronary artery calcification (CAC) analysis solution, AVIEW, to two major health screening centers of GC Green Cross i-Med, including the Gangnam and Gangbuk clinics. This implementation has established an integrated AI screening system at GC Green Cross i-Med's Gangnam and Gangbuk centers.
GC Green Cross i-Med has fully adopted AI solutions at each center to provide more precise and reliable screening services to a larger number of examinees. As a result, examinees can now have their lung nodules and cardiovascular condition evaluated simultaneously with just a single low-dose chest CT scan, and they can experience the same level of precise screening service whether they visit the Gangnam or Gangbuk center.
The key aspect of this contract is that Coreline Soft's AVIEW product has expanded beyond its existing role as a hospital diagnostic aid to become a premium screening tool focused on early detection for the general public. While minimizing radiation exposure, it can comprehensively assess the condition of vital organs such as the heart and lungs. Notably, the newly enhanced premium report has significantly improved the quality of communication between medical staff and patients.
This report provides 3D visualization of lesion location and condition, and is designed with an intuitive UI/UX to allow examinees to understand their health status on their own and actively participate in management. Along with automated calculation of quantified CAC scores, it offers visual communication features and various clinical support tools, making it highly useful in clinical settings.
Dr. Kim Sang-man, the representative director of GC Green Cross i-Med, stated, "With the introduction of AVIEW, we can now consistently provide premium-level AI chest screening services at both Gangnam and Gangbuk centers, greatly improving accessibility and convenience for examinees. We will continue to provide a highly reliable screening experience for both patients and medical staff through AI technology."
Kim Jin-guk, CEO of Coreline Soft, explained, "AVIEW is evolving from an existing hospital-centered diagnostic solution into an integrated AI screening platform that simultaneously realizes early detection, enhanced communication, and premium services for health screening centers." He added, "In particular, the CAC report combines clinical accuracy with visual communication power, enabling improvement in both screening quality and patient satisfaction."
Both companies plan to continue their collaboration in the future, jointly working on AI advancement based on the big data accumulated at each center and developing new screening services.
